{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T00:50:15Z","timestamp":1794444615556,"version":"4.9.1"},"reference-count":12,"publisher":"Informa UK Limited","issue":"9","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Biological Therapy"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1080\/14712598.2024.2394477","type":"journal-article","created":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T09:31:22Z","timestamp":1723887082000},"page":"869-871","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":18,"title":["The FDA approval of delandistrogene moxeparvovec-rokl for Duchenne muscular dystrophy: a critical examination of the evidence and regulatory process"],"prefix":"10.1080","volume":"24","author":[{"given":"Mehul","family":"Bhattacharyya","sequence":"first","affiliation":[{"name":"Department of Data Science, Arizona State University, Tempe, AZ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1594-1885","authenticated-orcid":false,"given":"Larry E","family":"Miller","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Miller Scientific, Johnson City, TN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna L.","family":"Miller","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Miller Scientific, Johnson City, TN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruemon","family":"Bhattacharyya","sequence":"additional","affiliation":[{"name":"Department of Public Affairs, University of California Los Angeles, Los Angeles, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,8,20]]},"reference":[{"key":"e_1_3_3_2_1","unstructured":"US Food and Drug Administration. FDA expands approval of gene therapy for patients with Duchenne muscular dystrophy. [cited 2024 Jun 22]. Available from: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-expands-approval-gene-therapy-patients-duchenne-muscular-dystrophy"},{"key":"e_1_3_3_3_1","unstructured":"US Food and Drug Administration. BLA integrated clinical and clinical pharmacology review memorandum. [cited 2024 Jun 22]. Available from: https:\/\/www.fda.gov\/media\/179486\/download?attachment"},{"key":"e_1_3_3_4_1","unstructured":"US Food and Drug Administration. Statistical review - Elevidys. [cited 2024 Jun 22]. Available from: https:\/\/www.fda.gov\/media\/179489\/download?attachment"},{"key":"e_1_3_3_5_1","unstructured":"US Food and Drug Administration. Summary of regulatory decision on biologics license application. [cited 2024 Jun 22]. Available from: https:\/\/www.fda.gov\/media\/179487\/download?attachment"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-020-01430-8"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-021-00248-3"},{"key":"e_1_3_3_8_1","unstructured":"US Food and Drug Administration. FDA approves first gene therapy for treatment of certain patients with Duchenne muscular dystrophy. [cited 2024 Jun 22]. Available from: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-gene-therapy-treatment-certain-patients-duchenne-muscular-dystrophy"},{"key":"e_1_3_3_9_1","unstructured":"US Food and Drug Administration. Center Director decisional memo - Elevidys. [cited 2024 Jun 22]. Available from: https:\/\/www.fda.gov\/media\/169707\/download"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2021.01.016"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1177\/1073110520935352"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4234"},{"key":"e_1_3_3_13_1","unstructured":"US Food and Drug Administration. Duchenne muscular dystrophy and related dystrophinopathies: developing drugs for treatment guidance for industry. [cited 2024 Jun 22]. Available from: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/duchenne-muscular-dystrophy-and-related-dystrophinopathies-developing-drugs-treatment-guidance"}],"container-title":["Expert Opinion on Biological Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14712598.2024.2394477","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T10:53:35Z","timestamp":1729594415000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14712598.2024.2394477"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,20]]},"references-count":12,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["10.1080\/14712598.2024.2394477"],"URL":"https:\/\/doi.org\/10.1080\/14712598.2024.2394477","relation":{},"ISSN":["1471-2598","1744-7682"],"issn-type":[{"value":"1471-2598","type":"print"},{"value":"1744-7682","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,20]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iebt20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iebt20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-06-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}